Last updated 2026-07-20
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$655.0M
total disclosed, rounds participated
Stages
—
Portfolio · 2
Twelve Financial Technologies Ltd.
Twelve is a credit-focused investment management firm specializing in providing Marketing Capital to digital consumer, entertainment and SaaS companies.
Venus Concept
A global medical aesthetic technology company developing minimally invasive and non-invasive medical aesthetic and hair restoration technologies.
Investment activity
2 portfolio exits on record.
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Longitude Capital's primary sector focus for investments?
- Longitude Capital primarily focuses its investments within the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.
- Can you name some notable portfolio companies of Longitude Capital?
- Longitude Capital's portfolio includes 89bio, which focuses on treatments for liver and metabolic disorders, and Venus Concept, a company utilizing RF-based technology for the medical aesthetics market.
- Has Longitude Capital had any notable exits recently?
- In November 2019, Longitude Capital had two notable exits through Public Offerings (POEvents) on NASDAQ: 89bio and Venus Concept. 89bio raised $85M during its POEvent.
- What is the typical investment range for Longitude Capital?
- Longitude Capital typically invests in the range of $10M to $60M.
- When was Longitude Capital founded?
- Longitude Capital was founded in 2019.
- What is the most recent investment activity by Longitude Capital?
- Longitude Capital's most recent recorded investment activity was in November 2019, which included a PIPE round.